ePrivacy and GPDR Cookie Consent by TermsFeed Generator

INDAPAMID STADA

1,5MG TBL PRO 100

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 13.10.2022
Interruption of marketing 08.09.2022 0124414, 0124416, 0151034, 0020031
Manufacturing reasons 31.10.2022
Resumption of marketing 23.02.2022
Interruption of marketing 17.01.2022 0120325, 0124414, 0124416, 0151034, 0020031
Manufacturing reasons 31.01.2022
Resumption of marketing 21.07.2020
Interruption of marketing 11.09.2019 0124414, 0124416, 0020031
Capacity/distribution reasons listopad 2019
Resumption of marketing 16.01.2019
Interruption of marketing 20.12.2018 0120325, 0124414, 0124416, 0012581, 0151034, 0020031
Commercial/marketing reasons 15.1.2019
Placing on the market 05.02.2010

All reports are available in the Overview.

Back to list